EPS will be bigger than last year. If these deferred projects get off the ground it will look damn damn cheap from a fundamental perspective
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025